Previous close | 2.1600 |
Open | 2.1400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.0601 - 2.1600 |
52-week range | 0.9700 - 4.4500 |
Volume | |
Avg. volume | 73,516 |
Market cap | 12.207M |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore key financial shifts, strategic acquisitions, and clinical advancements as PSTV navigates its Q1 2024 landscape.
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript March 5, 2024 Plus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.7, expectations were $-0.78. PSTV isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen. Welcome […]
Plus Therapeutics ( NASDAQ:PSTV ) Full Year 2023 Results Key Financial Results Revenue: US$4.91m (up by US$4.69m from...